Verity Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$369K Buy
4,254
+491
+13% +$47K 0.15% 160
2025
Q4
$361K Buy
3,763
+261
+7% +$25.4K 0.16% 165
2025
Q3
$334K Buy
3,502
+703
+25% +$64.6K 0.11% 180
2025
Q2
$244K Sell
2,799
-1,255
-31% -$106K 0.12% 174
2025
Q1
$364K Sell
4,054
-147
-3% -$13.2K 0.15% 134
2024
Q4
$313K Buy
4,201
+342
+9% +$29.6K 0.18% 122
2024
Q3
$348K Sell
3,859
-1,499
-28% -$126K 0.13% 140
2024
Q2
$422K Sell
5,358
-180
-3% -$14.8K 0.17% 116
2024
Q1
$483K Buy
5,538
+2,344
+73% +$200K 0.27% 95
2023
Q4
$263K Buy
3,194
+132
+4% +$10.1K 0.17% 147
2023
Q3
$240K Sell
3,062
-1,053
-26% -$88.1K 0.18% 143
2023
Q2
$363K Buy
4,115
+620
+18% +$53.4K 0.27% 102
2023
Q1
$282K Buy
+3,495
New +$285K 0.17% 132
2022
Q4
Sell
-4,866
Closed -$393K 197
2022
Q3
$393K Buy
+4,866
New +$437K 0.41% 84
2022
Q1
$508K Buy
+4,573
New +$483K 0.32% 100
2015
Q2
Sell
-14,318
Closed -$1.12M 108
2015
Q1
$1.12M Sell
14,318
-194
-1% -$14.7K 1.09% 30
2014
Q4
$1.05M Sell
14,512
-1,281
-8% -$89K 1.01% 26
2014
Q3
$978K Sell
15,793
-473
-3% -$30.1K 1.1% 23
2014
Q2
$1.04M Sell
16,266
-41
-0.3% -$2.49K 1.13% 22
2014
Q1
$1M Sell
16,307
-568
-3% -$33.1K 1.03% 22
2013
Q4
$968K Buy
+16,875
New +$957K 1.06% 20

Other funds holding MDT

Verity Asset Management's MDT Position: Q1 2026 in Review

Verity Asset Management increased its Medtronic (MDT) stake by 13% in Q1 2026, buying an estimated $47K and bringing the position to 4,254 shares worth $369K. The position accounts for 0.15% of the portfolio, ranked #160.

Verity Asset Management first reported a position in MDT in Q4 2013 and has held it in 21 quarters since. The position peaked at $1.12M in Q1 2015. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Verity Asset Management held 4,254 shares of Medtronic worth $369K as of Q1 2026.
  • Verity Asset Management bought 491 Medtronic shares in Q1 2026, an estimated $47K.
  • Medtronic made up 0.15% of Verity Asset Management's portfolio in Q1 2026, its #160 holding.
  • Verity Asset Management first reported a position in Medtronic in Q4 2013 and has held it in 21 quarters since.
  • Verity Asset Management's Medtronic position peaked at $1.12M in Q1 2015.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Verity Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.